Logo image
Sign in
Patient-reported outcomes in relapsed ovarian cancer: Results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD Alone
Journal article

Patient-reported outcomes in relapsed ovarian cancer: Results from a randomized Phase III study of trabectedin with pegylated liposomal doxorubicin (PLD) versus PLD Alone

Carolyn N. Krasner, Andres Poveda, Thomas J. Herzog, Jan B. Vermorken, Stanley B. Kaye, Antonio Nieto, Pilar L. Claret, Youn C. Park, Trilok Parekh and Bradley J. Monk
Gynecologic Oncology, Vol.127(1), pp.161-167
2012
PMID: 22765965

Metrics

6 Record Views

Details